Article Details

FDA Approves a New Atypical Antipsychotic With Less Adverse Effects

Retrieved on: 2021-06-01 19:47:52

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves a New Atypical Antipsychotic With Less Adverse Effects. View article details on hiswai:

Excerpt

This combination treatment of olanzapine and samidorphan caused ... commitment to developing new therapies that support patient-centered care,” ...

Article found on: www.psychiatrictimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up